Main CyTOF XT operator in the Immunology of Myeloid Malignancies Group. Current project: Investigating donor lymphocyte infusions in patients with AML using mass cytometry (CyTOF technology), in order to gain a better understanding of the differences in immunological responses between patients who stay in remission and those who relapse.